PUBLISHER: The Business Research Company | PRODUCT CODE: 1973401
PUBLISHER: The Business Research Company | PRODUCT CODE: 1973401
Disease management apps are software applications designed to assist individuals in monitoring, managing, and improving their health, particularly when dealing with chronic medical conditions or diseases. These apps incorporate various digital tools and wearables that enable healthcare professionals to remotely track patients' symptoms and activities and share information regarding medication adherence.
The main platform types for disease management apps include iOS, Android, and other platform types. iOS refers to a mobile operating system developed for Apple's mobile devices, including the iPhone, iPad, and iPod Touch. These apps are compatible with various devices such as smartphones, tablets, and wearables, and they are used for managing conditions such as obesity, cardiovascular issues, mental health, diabetes, and other medical indications.
Tariffs have influenced the disease management apps market by indirectly increasing development and deployment costs through higher prices for imported wearables, sensors, cloud infrastructure hardware, and supporting digital health devices. These impacts are most visible across wearable-integrated app segments and smartphone-based platforms, with regions such as Asia-Pacific and North America experiencing supply chain adjustments due to their reliance on global electronics manufacturing and software services. Tariff pressures have slowed device affordability in some end-user groups while pushing developers to optimize software-only solutions and cloud-based disease management platforms. On the positive side, tariffs have encouraged localized development, regional partnerships, and innovation in cost-efficient app architectures, strengthening long-term resilience within the disease management apps ecosystem.
The disease management apps market research report is one of a series of new reports from The Business Research Company that provides disease management apps market statistics, including disease management apps industry global market size, regional shares, competitors with a disease management apps market share, detailed disease management apps market segments, market trends and opportunities, and any further data you may need to thrive in the disease management apps industry. This disease management apps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The disease management apps market size has grown rapidly in recent years. It will grow from $13.05 billion in 2025 to $14.75 billion in 2026 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing smartphone penetration, growing adoption of digital health solutions, demand for continuous patient monitoring, expansion of telehealth services.
The disease management apps market size is expected to see rapid growth in the next few years. It will grow to $24.18 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to advancements in AI-based health analytics, integration of wearable health devices, increasing focus on preventive healthcare, growing acceptance of remote care models, rising healthcare cost optimization initiatives. Major trends in the forecast period include remote patient monitoring integration, personalized disease care pathways, medication adherence optimization, real-time health data analytics, wearable-enabled chronic care management.
The rising prevalence of chronic disorders is anticipated to drive the expansion of the disease management apps market in the coming years. Chronic conditions, also referred to as chronic diseases, are long-term medical conditions that last for an extended duration, generally three months or longer. Disease management apps are used in chronic care to offer tools for symptom tracking, medication logging, vital sign monitoring, and trigger identification. For instance, in June 2024, according to the National Health Service, a UK-based government body, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition characterized by elevated blood sugar levels that are not high enough to be classified as diabetes) in 2023, reflecting an 18% rise from 3,065,825 cases in 2022. Thus, the growing burden of chronic conditions is contributing to the growth of the disease management apps market going forward.
Major companies operating in the disease management apps market are emphasizing technological innovations such as GenAI to enhance their profitability. GenAI is an artificial intelligence technology that automates the generation of clinical summary reports and improves communication between patients and healthcare providers. For example, in August 2023, Huma Therapeutics, a UK-based healthcare technology company, introduced a GenAI-powered artificial intelligence (AI) disease management platform using Google Cloud. This advanced technology is specifically engineered to integrate into its disease management platform to strengthen decision-making tools for diagnostics, treatment, and recommendations.
In February 2023, Amazon.com Inc. acquired the One Medical app from 1Life Healthcare, Inc. for approximately $3.9 billion. This strategic move allows Amazon.com Inc. to expand its services, offering various disease management features such as remote visits, 24/7 on-demand virtual care services, and on-demand video chats through the One Medical app. 1Life Healthcare, Inc. is a virtual care provider of the disease management app One Medical based in the United States.
Major companies operating in the disease management apps market are Alphabet Inc.; International Business Machines Corporation; Siemens Healthineers AG; Koninklijke Philips N.V.; Garmin International Inc.; DexCom Inc.; Epic Systems Corporation; Teladoc Inc.; Fitbit LLC; athenahealth Inc.; Allscripts Healthcare Solutions Inc.; Omada Health Inc.; Calm.com Inc.; Livongo Health Inc.; American Well Corporation; MyFitnessPal Inc.; Talkspace Inc.; Noom Inc.; Ada Health GmbH; Healthy.io Ltd.; Medisafe International LLC; Sleep Cycle AB; Buoy Health Inc.; Azumio Inc.; Propeller Health Inc.; Welldoc Inc.; Informed Data Systems Inc.; Curable Inc.
North America was the largest region in the disease management apps market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the disease management apps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the disease management apps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The disease management apps market includes revenues earned by entities by provide disease management services such as medication management, health tracking, and e-prescribing software. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The disease management apps market consists of sales of wearable devices such as sensors, remote patient monitoring devices, and fitness trackers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Disease Management Apps Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses disease management apps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for disease management apps ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The disease management apps market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.